{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:35:21Z","timestamp":1791311721124,"version":"4.3.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s00018-013-1498-7","type":"journal-article","created":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T12:43:12Z","timestamp":1383223392000},"page":"2517-2533","source":"Crossref","is-referenced-by-count":37,"title":["Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer"],"prefix":"10.1007","volume":"71","author":[{"given":"Mohammad","family":"Jaber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Maoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Kancharla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Agranovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Peretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorina","family":"Grisaru-Granovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Uziely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Bar-Shavit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,1]]},"reference":[{"key":"1498_CR1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-5793(02)02775-8","volume":"520","author":"S Takeda","year":"2002","unstructured":"Takeda S, Kadowaki S, Haga T, Takaesu H, Mitaku S (2002) Identification of G protein-coupled receptor genes from the human genome sequence. FEBS Lett 520:97\u2013101","journal-title":"FEBS Lett"},{"key":"1498_CR2","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1124\/mol.63.6.1256","volume":"63","author":"R Fredriksson","year":"2003","unstructured":"Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB (2003) The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63:1256\u20131272","journal-title":"Mol Pharmacol"},{"key":"1498_CR3","first-page":"1","volume":"2","author":"LF Kolakowski Jr","year":"1994","unstructured":"Kolakowski LF Jr (1994) GCRDb: a G-protein-coupled receptor database. Receptors Channels 2:1\u20137","journal-title":"Receptors Channels"},{"key":"1498_CR4","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/emboj\/18.7.1723","volume":"18","author":"J Bockaert","year":"1999","unstructured":"Bockaert J, Pin JP (1999) Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J 18:1723\u20131729","journal-title":"EMBO J"},{"key":"1498_CR5","first-page":"339","volume":"7","author":"MC Lagerstrom","year":"2008","unstructured":"Lagerstrom MC, Schioth HB (2008) Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev 7:339\u2013357","journal-title":"Nat Rev"},{"key":"1498_CR6","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/0092-8674(91)90261-V","volume":"64","author":"TK Vu","year":"1991","unstructured":"Vu TK, Hung DT, Wheaton VI, Coughlin SR (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057\u20131068","journal-title":"Cell"},{"key":"1498_CR7","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1439-7633(20021004)3:10<963::AID-CBIC963>3.0.CO;2-9","volume":"3","author":"RE Stenkamp","year":"2002","unstructured":"Stenkamp RE, Teller DC, Palczewski K (2002) Crystal structure of rhodopsin: a G-protein-coupled receptor. ChemBioChem 3:963\u2013967","journal-title":"ChemBioChem"},{"key":"1498_CR8","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1074\/jbc.M509525200","volume":"281","author":"S Swift","year":"2006","unstructured":"Swift S, Leger AJ, Talavera J, Zhang L, Bohm A, Kuliopulos A (2006) Role of the PAR1 receptor 8th helix in signaling: the 7-8-1 receptor activation mechanism. J Biol Chem 281:4109\u20134116","journal-title":"J Biol Chem"},{"key":"1498_CR9","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1096\/fj.00-0438rev","volume":"15","author":"T Kenakin","year":"2001","unstructured":"Kenakin T (2001) Inverse, protean, and ligand-selective agonism: matters of receptor conformation. Faseb J 15:598\u2013611","journal-title":"Faseb J"},{"key":"1498_CR10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1124\/jpet.110.173948","volume":"336","author":"T Kenakin","year":"2011","unstructured":"Kenakin T (2011) Functional selectivity and biased receptor signaling. J Pharm Exp Ther 336:296\u2013302","journal-title":"J Pharm Exp Ther"},{"key":"1498_CR11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.pharmtox.010909.105800","volume":"52","author":"E Reiter","year":"2012","unstructured":"Reiter E, Ahn S, Shukla AK, Lefkowitz RJ (2012) Molecular mechanism of beta-arrestin-biased agonism at seven-transmembrane receptors. Annu Rev Pharmacol Toxicol 52:179\u2013197","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1498_CR12","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1126\/science.1150577","volume":"318","author":"V Cherezov","year":"2007","unstructured":"Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, Stevens RC (2007) High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318:1258\u20131265","journal-title":"Science"},{"key":"1498_CR13","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature07101","volume":"454","author":"T Warne","year":"2008","unstructured":"Warne T, Serrano-Vega MJ, Baker JG, Moukhametzianov R, Edwards PC, Henderson R, Leslie AG, Tate CG, Schertler GF (2008) Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 454:486\u2013491","journal-title":"Nature"},{"key":"1498_CR14","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1126\/science.1164772","volume":"322","author":"VP Jaakola","year":"2008","unstructured":"Jaakola VP, Griffith MT, Hanson MA, Cherezov V, Chien EY, Lane JR, Ijzerman AP, Stevens RC (2008) The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322:1211\u20131217","journal-title":"Science"},{"key":"1498_CR15","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.str.2008.05.001","volume":"16","author":"MA Hanson","year":"2008","unstructured":"Hanson MA, Cherezov V, Griffith MT, Roth CB, Jaakola VP, Chien EY, Velasquez J, Kuhn P, Stevens RC (2008) A specific cholesterol binding site is established by the 2.8 a structure of the human beta2-adrenergic receptor. Structure\u00a016:897\u2013905","journal-title":"Structure"},{"key":"1498_CR16","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1126\/science.1197410","volume":"330","author":"EY Chien","year":"2010","unstructured":"Chien EY, Liu W, Zhao Q, Katritch V, Han GW, Hanson MA, Shi L, Newman AH, Javitch JA, Cherezov V, Stevens RC (2010) Structure of the human dopamine D3 receptor in complex with a D2\/D3 selective antagonist. Science 330:1091\u20131095","journal-title":"Science"},{"key":"1498_CR17","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.1194396","volume":"330","author":"B Wu","year":"2010","unstructured":"Wu B, Chien EY, Mol CD, Fenalti G, Liu W, Katritch V, Abagyan R, Brooun A, Wells P, Bi FC, Hamel DJ, Kuhn P, Handel TM, Cherezov V, Stevens RC (2010) Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330:1066\u20131071","journal-title":"Science"},{"key":"1498_CR18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature10939","volume":"485","author":"H Wu","year":"2012","unstructured":"Wu H, Wacker D, Mileni M, Katritch V, Han GW, Vardy E, Liu W, Thompson AA, Huang XP, Carroll FI, Mascarella SW, Westkaemper RB, Mosier PD, Roth BL, Cherezov V, Stevens RC (2012) Structure of the human kappa-opioid receptor in complex with JDTic. Nature 485:327\u2013332","journal-title":"Nature"},{"key":"1498_CR19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/eji.200738101","volume":"38","author":"D Hereld","year":"2008","unstructured":"Hereld D, Jin T (2008) Slamming the DOR on chemokine receptor signaling: heterodimerization silences ligand-occupied CXCR4 and delta-opioid receptors. Eur J Immunol 38:334\u2013337","journal-title":"Eur J Immunol"},{"key":"1498_CR20","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1093\/emboj\/20.10.2497","volume":"20","author":"M Mellado","year":"2001","unstructured":"Mellado M, Rodriguez-Frade JM, Vila-Coro AJ, Fernandez S, de Martin Ana A, Jones DR, Toran JL, Martinez AC (2001) Chemokine receptor homo- or heterodimerization activates distinct signaling pathways. EMBO J 20:2497\u20132507","journal-title":"EMBO J"},{"key":"1498_CR21","doi-asserted-by":"crossref","first-page":"30062","DOI":"10.1074\/jbc.M705302200","volume":"282","author":"D Sohy","year":"2007","unstructured":"Sohy D, Parmentier M, Springael JY (2007) Allosteric transinhibition by specific antagonists in CCR2\/CXCR4 heterodimers. J Biol Chem 282:30062\u201330069","journal-title":"J Biol Chem"},{"key":"1498_CR22","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1073\/pnas.0700763104","volume":"104","author":"JN McLaughlin","year":"2007","unstructured":"McLaughlin JN, Patterson MM, Malik AB (2007) Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization. Proc Natl Acad Sci USA 104:5662\u20135667","journal-title":"Proc Natl Acad Sci USA"},{"key":"1498_CR23","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1161\/CIRCULATIONAHA.105.587758","volume":"113","author":"AJ Leger","year":"2006","unstructured":"Leger AJ, Jacques SL, Badar J, Kaneider NC, Derian CK, Andrade-Gordon P, Covic L, Kuliopulos A (2006) Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis. Circulation 113:1244\u20131254","journal-title":"Circulation"},{"key":"1498_CR24","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ni1525","volume":"8","author":"NC Kaneider","year":"2007","unstructured":"Kaneider NC, Leger AJ, Agarwal A, Nguyen N, Perides G, Derian C, Covic L, Kuliopulos A (2007) \u2018Role reversal\u2019 for the receptor PAR1 in sepsis-induced vascular damage. Nat Immunol 8:1303\u20131312","journal-title":"Nat Immunol"},{"key":"1498_CR25","doi-asserted-by":"crossref","first-page":"14910","DOI":"10.1074\/jbc.271.25.14910","volume":"271","author":"S Nystedt","year":"1996","unstructured":"Nystedt S, Ramakrishnan V, Sundelin J (1996) The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor. J Biol Chem 271:14910\u201314915","journal-title":"J Biol Chem"},{"key":"1498_CR26","doi-asserted-by":"crossref","first-page":"13502","DOI":"10.1074\/jbc.275.18.13502","volume":"275","author":"PJ O\u2019Brien","year":"2000","unstructured":"O\u2019Brien PJ, Prevost N, Molino M, Hollinger MK, Woolkalis MJ, Woulfe DS, Brass LF (2000) Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1. J Biol Chem 275:13502\u201313509","journal-title":"J Biol Chem"},{"key":"1498_CR27","doi-asserted-by":"crossref","first-page":"16466","DOI":"10.1074\/jbc.271.28.16466","volume":"271","author":"BD Blackhart","year":"1996","unstructured":"Blackhart BD, Emilsson K, Nguyen D, Teng W, Martelli AJ, Nystedt S, Sundelin J, Scarborough RM (1996) Ligand cross-reactivity within the protease-activated receptor family. J Biol Chem 271:16466\u201316471","journal-title":"J Biol Chem"},{"key":"1498_CR28","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1161\/ATVBAHA.111.238261","volume":"31","author":"LM Sevigny","year":"2012","unstructured":"Sevigny LM, Austin KM, Zhang P, Kasuda S, Koukos G, Sharifi S, Covic L, Kuliopulos A (2012) Protease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasia. Arterioscler Thromb Vasc Biol 31:e100\u2013e106","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1498_CR29","doi-asserted-by":"crossref","first-page":"11203","DOI":"10.1074\/jbc.M112.439950","volume":"288","author":"H Lin","year":"2013","unstructured":"Lin H, Trejo J (2013) Transactivation of the PAR1-PAR2 heterodimer by thrombin elicits beta-arrestin-mediated endosomal signaling. J Biol Chem 288:11203\u201311215","journal-title":"J Biol Chem"},{"key":"1498_CR30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/plac.2002.0887","volume":"24","author":"JC Cross","year":"2003","unstructured":"Cross JC, Baczyk D, Dobric N, Hemberger M, Hughes M, Simmons DG, Yamamoto H, Kingdom JC (2003) Genes, development and evolution of the placenta. Placenta 24:123\u2013130","journal-title":"Placenta"},{"key":"1498_CR31","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.7985020","volume":"266","author":"JC Cross","year":"1994","unstructured":"Cross JC, Werb Z, Fisher SJ (1994) Implantation and the placenta: key pieces of the development puzzle. Science 266:1508\u20131518","journal-title":"Science"},{"issue":"Suppl A","key":"1498_CR32","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/j.placenta.2006.01.011","volume":"27","author":"JD Aplin","year":"2006","unstructured":"Aplin JD, Straszewski-Chavez SL, Kalionis B, Dunk C, Morrish D, Forbes K, Baczyk D, Rote N, Malassine A, Knofler M (2006) Trophoblast differentiation: progenitor cells, fusion and migration: a workshop report. Placenta 27(Suppl A):S141\u2013S143","journal-title":"Placenta"},{"key":"1498_CR33","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/jcp.21625","volume":"218","author":"S Grisaru-Granovsky","year":"2009","unstructured":"Grisaru-Granovsky S, Maoz M, Barzilay O, Yin YJ, Prus D, Bar-Shavit R (2009) Protease activated receptor-1, PAR1, promotes placenta trophoblast invasion and beta-catenin stabilization. J Cell Physiol 218:512\u2013521","journal-title":"J Cell Physiol"},{"key":"1498_CR34","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0143-4004(92)90051-T","volume":"13","author":"O Genbacev","year":"1992","unstructured":"Genbacev O, Schubach SA, Miller RK (1992) Villous culture of first trimester human placenta\u2013model to study extravillous trophoblast (EVT) differentiation. Placenta 13:439\u2013461","journal-title":"Placenta"},{"key":"1498_CR35","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.placenta.2005.09.007","volume":"27","author":"P Bose","year":"2006","unstructured":"Bose P, Kadyrov M, Goldin R, Hahn S, Backos M, Regan L, Huppertz B (2006) Aberrations of early trophoblast differentiation predispose to pregnancy failure: lessons from the anti-phospholipid syndrome. Placenta 27:869\u2013875","journal-title":"Placenta"},{"key":"1498_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biocel.2004.05.014","volume":"37","author":"P Bischof","year":"2005","unstructured":"Bischof P, Irminger-Finger I (2005) The human cytotrophoblastic cell, a mononuclear chameleon. Int J Biochem Cell Biol 37:1\u201316","journal-title":"Int J Biochem Cell Biol"},{"key":"1498_CR37","doi-asserted-by":"crossref","first-page":"e11135","DOI":"10.1371\/journal.pone.0011135","volume":"5","author":"I Cohen","year":"2010","unstructured":"Cohen I, Maoz M, Turm H, Grisaru-Granovsky S, Maly B, Uziely B, Weiss E, Abramovitch R, Gross E, Barzilay O, Qiu Y, Bar-Shavit R (2010) Etk\/Bmx regulates proteinase-activated-receptor1 (PAR1) in breast cancer invasion: signaling partners, hierarchy and physiological significance. PLoS ONE 5:e11135","journal-title":"PLoS ONE"},{"key":"1498_CR38","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1139\/y97-110","volume":"75","author":"MD Hollenberg","year":"1997","unstructured":"Hollenberg MD, Saifeddine M, al-Ani B, Kawabata A (1997) Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Can J Physiol Pharmacol 75:832\u2013841","journal-title":"Can J Physiol Pharmacol"},{"key":"1498_CR39","first-page":"624","volume":"38","author":"NH Colburn","year":"1978","unstructured":"Colburn NH, Bruegge WF, Bates JR, Gray RH, Rossen JD, Kelsey WH, Shimada T (1978) Correlation of anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cells. Cancer Res 38:624\u2013634","journal-title":"Cancer Res"},{"key":"1498_CR40","first-page":"1441","volume":"41","author":"MG Dodson","year":"1981","unstructured":"Dodson MG, Slota J, Lange C, Major E (1981) Distinction of the phenotypes of in vitro anchorage-independent soft-agar growth and in vivo tumorigenicity in the nude mouse. Cancer Res 41:1441\u20131446","journal-title":"Cancer Res"},{"key":"1498_CR41","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1161\/ATVBAHA.111.238865","volume":"12","author":"R Pawlinski","year":"2011","unstructured":"Pawlinski R, Holinstat M (2011) We can do it together: PAR1\/PAR2 heterodimer signaling in VSMCs. Arterioscler Thromb Vasc Biol 12:2775\u20132776","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1498_CR42","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1128\/MCB.26.8.3231-3242.2006","volume":"26","author":"MM Paing","year":"2006","unstructured":"Paing MM, Johnston CA, Siderovski DP, Trejo J (2006) Clathrin adaptor AP2 regulates thrombin receptor constitutive internalization and endothelial cell resensitization. Mol Cell Biol 26:3231\u20133242","journal-title":"Mol Cell Biol"},{"key":"1498_CR43","doi-asserted-by":"crossref","first-page":"15137","DOI":"10.1074\/jbc.M109.072843","volume":"285","author":"H Turm","year":"2010","unstructured":"Turm H, Maoz M, Katz V, Yin YJ, Offermanns S, Bar-Shavit R (2010) Protease-activated receptor-1 (PAR1) acts via a novel Galpha13-dishevelled axis to stabilize beta-catenin levels. J Biol Chem 285:15137\u201315148","journal-title":"J Biol Chem"},{"key":"1498_CR44","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1124\/mol.104.006072","volume":"67","author":"L Stalheim","year":"2005","unstructured":"Stalheim L, Ding Y, Gullapalli A, Paing MM, Wolfe BL, Morris DR, Trejo J (2005) Multiple independent functions of arrestins in the regulation of protease-activated receptor-2 signaling and trafficking. Mol Pharmacol 67:78\u201387","journal-title":"Mol Pharmacol"},{"key":"1498_CR45","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1124\/mol.109.062018","volume":"77","author":"KL McCoy","year":"2010","unstructured":"McCoy KL, Traynelis SF, Hepler JR (2010) PAR1 and PAR2 couple to overlapping and distinct sets of G proteins and linked signaling pathways to differentially regulate cell physiology. Mol Pharmacol 77:1005\u20131015","journal-title":"Mol Pharmacol"},{"key":"1498_CR46","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.coph.2009.10.007","volume":"10","author":"MJ Lohse","year":"2010","unstructured":"Lohse MJ (2010) Dimerization in GPCR mobility and signaling. Curr Opin Pharmacol 10:53\u201358","journal-title":"Curr Opin Pharmacol"},{"key":"1498_CR47","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1158\/0008-5472.CAN-08-0419","volume":"68","author":"HH Versteeg","year":"2008","unstructured":"Versteeg HH, Schaffner F, Kerver M, Ellies LG, Andrade-Gordon P, Mueller BM, Ruf W (2008) Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice. Cancer Res 68:7219\u20137227","journal-title":"Cancer Res"},{"key":"1498_CR48","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1182\/blood-2010-06-289314","volume":"116","author":"F Schaffner","year":"2010","unstructured":"Schaffner F, Versteeg HH, Schillert A, Yokota N, Petersen LC, Mueller BM, Ruf W (2010) Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development. Blood 116:6106\u20136113","journal-title":"Blood"},{"key":"1498_CR49","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1158\/0008-5472.CAN-05-1735","volume":"66","author":"DR Morris","year":"2006","unstructured":"Morris DR, Ding Y, Ricks TK, Gullapalli A, Wolfe BL, Trejo J (2006) Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells. Cancer Res 66:307\u2013314","journal-title":"Cancer Res"},{"key":"1498_CR50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/path.1338","volume":"200","author":"SC Even-Ram","year":"2003","unstructured":"Even-Ram SC, Grisaru-Granovsky S, Pruss D, Maoz M, Salah Z, Yong-Jun Y, Bar-Shavit R (2003) The pattern of expression of protease-activated receptors (PARs) during early trophoblast development. J Pathol 200:47\u201352","journal-title":"J Pathol"},{"key":"1498_CR51","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0002-9440(10)63484-0","volume":"163","author":"PJ O\u2019Brien","year":"2003","unstructured":"O\u2019Brien PJ, Koi H, Parry S, Brass LF, Strauss JF, Wang LP, Tomaszewski JE, Christenson LK (2003) Thrombin receptors and protease-activated receptor-2 in human placentation: receptor activation mediates extravillous trophoblast invasion in vitro. Am J Pathol 163:1245\u20131254","journal-title":"Am J Pathol"}],"updated-by":[{"DOI":"10.1007\/s00018-016-2424-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T00:00:00Z","timestamp":1480464000000}}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-013-1498-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-013-1498-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-013-1498-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T14:29:47Z","timestamp":1558535387000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-013-1498-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,1]]},"references-count":51,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["1498"],"URL":"https:\/\/doi.org\/10.1007\/s00018-013-1498-7","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00018-016-2424-6","asserted-by":"object"}]},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,1]]}}}